Targeting papain-like protease for broad-spectrum coronavirus inhibition

[1]  Jian-Piao Cai,et al.  Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity , 2021, Science Advances.

[2]  Junhao Hu,et al.  Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2 , 2021, Cell Chemical Biology.

[3]  L. Guddat,et al.  High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors , 2021, Protein & Cell.

[4]  Ronald A. Li,et al.  Clofazimine broadly inhibits coronaviruses including SARS-CoV-2 , 2021, Nature.

[5]  Wenjie Zhu,et al.  The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery , 2021, Nature communications.

[6]  Benjamin A. Shoemaker,et al.  PubChem in 2021: new data content and improved web interfaces , 2020, Nucleic Acids Res..

[7]  J. Chan,et al.  Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters , 2020, Nature Microbiology.

[8]  Meitian Wang,et al.  Crystal structure of SARS-CoV-2 papain-like protease , 2020, Acta Pharmaceutica Sinica B.

[9]  Gerbrand J. van der Heden van Noort,et al.  Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2 , 2020, The EMBO journal.

[10]  Cooper A. Taylor,et al.  Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors , 2020, Nature Communications.

[11]  K. Yuen,et al.  Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKε , 2020, The Journal of Immunology.

[12]  K. To,et al.  Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target , 2020, Science Advances.

[13]  G. Hummer,et al.  Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity , 2020, Nature.

[14]  C. Svendsen,et al.  Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection , 2020, Cell Reports Medicine.

[15]  D. Agard,et al.  A molecular pore spans the double membrane of the coronavirus replication organelle , 2020, Science.

[16]  T. Akkoç,et al.  Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2. , 2020, Advances in experimental medicine and biology.

[17]  R. Schwartz,et al.  Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.

[18]  K. To,et al.  Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Karthik Srinivasan,et al.  Decoupling deISGylating and deubiquitinating activities of the MERS virus papain-like protease , 2019, Antiviral Research.

[20]  Yi Guan,et al.  Two Methods for Mapping and Visualizing Associated Data on Phylogeny Using Ggtree. , 2018, Molecular biology and evolution.

[21]  Z. Mu,et al.  Structural Insight Into Conformational Changes Induced by ATP Binding in a Type III Secretion-Associated ATPase From Shigella flexneri , 2018, Front. Microbiol..

[22]  Sudhir Kumar,et al.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.

[23]  Fabian Sievers,et al.  Clustal Omega for making accurate alignments of many protein sequences , 2018, Protein science : a publication of the Protein Society.

[24]  S. Perlman,et al.  Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice , 2017, Proceedings of the National Academy of Sciences.

[25]  Roland Eils,et al.  Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..

[26]  Jie Zhou,et al.  A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication. , 2016, The Journal of antimicrobial chemotherapy.

[27]  Susanna K. P. Lau,et al.  Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease , 2015, Clinical Microbiology Reviews.

[28]  A. Mesecar,et al.  The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds , 2014, Antiviral Research.

[29]  A. Mesecar,et al.  Catalytic Function and Substrate Specificity of the Papain-Like Protease Domain of nsp3 from the Middle East Respiratory Syndrome Coronavirus , 2014, Journal of Virology.

[30]  Michael W. Wilson,et al.  X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases , 2014, Journal of medicinal chemistry.

[31]  E. Arutyunova,et al.  ISG15 Arg151 and the ISG15-Conjugating Enzyme UbE1L Are Important for Innate Immune Control of Sindbis Virus , 2008, Journal of Virology.

[32]  Wentao Fu,et al.  A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication , 2008, Proceedings of the National Academy of Sciences.

[33]  Zhongbin Chen,et al.  The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating Activity , 2005, Journal of Virology.